The pioneering immuno-oncology treatment OPDIVO expanded its portfolio with the introduction of an option with subcutaneous administration. While the story to be told was simple, the launch was relentless sprint and a heavy lift. Developed full menu of tactics for both HCP and clinical nurse teams available for use on Day 1.